Our People

Nuclear medicine requires convergent expertise:

clinical knowledge of imaging interpretation, understanding of radiopharmaceuticals and tracer behavior, operational precision in protocol implementation, and sustained engagement with regulatory requirements. Finding individuals with depth across all these dimensions is uncommon. TPPL's clinical leadership represents two decades of experience across institutional settings and regulatory environments.

Partnership

TPPL × Valentis Cancer Care, Meerut

At Valentis Cancer Care (Meerut), the brief is unglamorous and exacting: take PET-CT from a test to a platform. Start with hardware that won’t become the bottleneck. The department runs a GE Discovery IQ 3-Ring PET/CT with the LightBurst PET detector for small-lesion clarity, and Q.Clear reconstruction for reproducible SUVs—useful when an oncologist is tracking real response, not radiology prose. The platform is tuned for high image quality at lower dose and faster scans, which matters when the day is oncology-heavy and the waiting room is full of fasting patients.

Partner With Us

Engage on a project plan, not a promise.

Start with a 60-minute scoping. Bring five inputs: current modalities and volumes; case-mix by indication; people roster and competencies; compliance status and audit history; reporting samples with TATs. Expect a gap map—operations, reporting, safety, training, and therapy-readiness.

Receive a centre blueprint. An implementation plan with day-0/30/60/90 milestones: SOP stack; QC calendar; appointment templates; report templates; training tracks; compliance remediations; MDT cadence and referrer communications.

Lock operating metrics. Uptime targets; on-time starts; QC pass thresholds; report TAT by indication; read-to-referrer feedback loop closure; incident response timelines; therapy-day performance measures (prep accuracy, counselling completion, discharge timings).

Go To Top